Table 1. Methods evaluated during the interlaboratory test performance study.
Methods | M1 | M2 | Ma | M3 | M4 | M5 | M6 | ||
---|---|---|---|---|---|---|---|---|---|
Type of amplification | End-point PCR | End-point PCR | End-point PCR | Real-time PCR | Real-time PCR | Real-time PCR | Real-time PCR | ||
Nested-PCR | Duplex nested-PCR | Nested-PCR followed by RFLP analysis | Simplex PCR | Simplex PCR | Triplex PCR | Triplex PCR | |||
Targeted area of the genome | 16S rDNA | SecY gene | 16S rDNA | 16S rDNA | SecY gene | map gene | unknown | ||
Bibliographical references | [11, 14] | [18] [13, 15] | [11] | [15] | [16] | [17] | Under-patent (IPADLAB) | ||
Evaluation of analytical specificity | Number of laboratoriesa | 14 | 12 (13)c | 5 (6)c | 7 | 10 | 7 (8)c | 9 | |
Number of resultsab | overall | 336 | 288 (312) | 120 (144) | 168 | 240 | 168 (192) | 216 | |
from positive samples | 210 | 180 (195) | 75 (90) | 105 | 150 | 105 (120) | 135 | ||
from negative samples | 126 | 108 (117) | 45 (54) | 63 | 90 | 63 (72) | 81 | ||
Number of indeterminate resultsa | overall | 16 | 11 (11) | 3 (3) | 4 | 8 | 5 (11) | 14 | |
from positive samples | 9 | 8 (8) | 2 (2) | 0 | 3 | 2 (4) | 5 | ||
from negative samples | 7 | 3 (3) | 1 (1) | 4 | 5 | 3 (7) | 9 | ||
Rate of indeterminate results (%)a | overall | 4.76 | 3.82 (3.53) | 2.50 (2.08) | 2.38 | 3.33 | 2.98 (5.73) | 6.48 | |
from positive samples | 4.29 | 4.44 (4.10) | 2.67 (2.22) | 0.00 | 2.00 | 1.90 (3.33) | 3.70 | ||
from negative samples | 5.56 | 2.78 (2.56) | 2.22 (1.85) | 6.35 | 5.56 | 4.76 (9.72) | 10.23 | ||
Evaluation of analytical sensitivity, repeatability and reproducibility | Number of laboratories | 5 | 5 | 2 | 5 | 5 | 5 | 5 | |
Number of results | 375 | 375 | 150 | 375 | 375 | 375 | 375 |
aThe number in brackets indicates the value without exclusion of data
bThe number of results was calculated as follows: number of laboratories x number of results per method and laboratory (overall, from positive samples and from negative samples). The number of results per method and laboratory from positive samples was 15; the number of results per method and laboratory from negative samples was 9 and the number of overall results per method and laboratory was 24
cExclusion of results of P6 for method M2, results of P5 for method Ma and results of P9 for method M5 (considered as outliers, for more details: see “outlier results” section)